Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01041755
What this trial is testing

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

Who this might be right for
Hepatic Encephalopathy
Centro Regional para el Estudio de las Enfermedades Digestivas 30
Large-scale testing (Phase 3)Study completedNCT00106366
What this trial is testing

Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 389
Early research (Phase 1)Study completedNCT02933853
What this trial is testing

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 61
Not applicableStudy completedNCT00698269
What this trial is testing

An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 5,926
Large-scale testing (Phase 3)Active Not RecruitingNCT07076199
What this trial is testing

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 877
Large-scale testing (Phase 3)Study completedNCT03377699
What this trial is testing

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 225
Post-approval studies (Phase 4)Study completedNCT01828970
What this trial is testing

Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients

Who this might be right for
Diabetes Mellitus
Centre Europeen d'Etude du Diabete 38
Testing effectiveness (Phase 2)Study completedNCT01510093
What this trial is testing

Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)

Who this might be right for
Type 2 Diabetes Mellitus
Aarhus University Hospital 10
Early research (Phase 1)Study completedNCT02131246
What this trial is testing

A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 33
Post-approval studies (Phase 4)Study completedNCT03659799
What this trial is testing

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal 40
Post-approval studies (Phase 4)Study completedNCT01649570
What this trial is testing

Safety and Efficacy of Insulin Aspart in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 123
Post-approval studies (Phase 4)Study completedNCT00676819
What this trial is testing

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 19
Post-approval studies (Phase 4)Study completedNCT00537277
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 161
Not applicableStudy completedNCT00704223
What this trial is testing

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 619
Large-scale testing (Phase 3)Study completedNCT03268005
What this trial is testing

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,264
Large-scale testing (Phase 3)Study completedNCT00095082
What this trial is testing

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 447
Early research (Phase 1)Study completedNCT00969592
What this trial is testing

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers

Who this might be right for
Diabetes
Profil Institut für Stoffwechselforschung GmbH 12
Testing effectiveness (Phase 2)Study completedNCT00624767
What this trial is testing

Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus
Nastech Pharmaceutical Company, Inc. 18
Not applicableStudy completedNCT01536600
What this trial is testing

Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 33,010
Early research (Phase 1)Study completedNCT01538511
What this trial is testing

Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 59
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation